Provider Review · v3.0 Rubric · Updated October 16, 2026
Sesame Review
Updated October 16, 2026 with prices and facts re-checked October 14, 2026.
Cash-pay telehealth marketplace with same-day GLP-1 appointments. Video visit pricing is among the lowest in the market. Best for patients who want a one-time visit, not a subscription program.
Not in the May 2026 rankingQuick-access GLP-1New York, NYUpdated October 16, 2026
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated October 16, 2026
Key facts
Specialty
Quick-access GLP-1
Headquarters
New York, NY
v3.0 rubric score
Not scored (outside the May 2026 ranking)
Pricing & model
Starting at $25-$150/visit · Video Telehealth · Labs not included · varies
Peptides & medications
Semaglutide, Tirzepatide
States served
All 50 states + DC (telehealth)
Who Sesame is best for
Best for: one-time prescribing visits, not subscription programs. Trade-off: medication cost is separate; no ongoing program.
How Sesame compares to NexLife (Editor’s Pick)
NexLife is the v3.0 Editor’s Pick for both semaglutide ($119/mo, 12-month plan) and tirzepatide ($139/mo, 12-month plan) categories, scoring 94/100 on the May 2026 review (on its live pages (read October 14, 2026) we can verify a named medical director, three named 503A pharmacies, flat pricing at every dose and written regulatory disclosures; included labs, published cohort outcomes and per-vial certificates of analysis are not stated). Sesame's not scored places it in the lower tier of the directory. Patients who want a flat price on a 12-month plan charged monthly and a named medical director should compare against NexLife.
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $125 (6-mo, save $84) · $132 (3-mo, save $21) · $139 (monthly).
Includes: medication, all MD/DO visits, messaging (lab work not stated on its pages), personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Klarna & Affirm financing accepted at checkout (FAQ).
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
The v3.0 six-pillar transparency rubric
Every provider is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full methodology.
Editorial team
Reviewed by Dr. Sam Saberian, medically reviewed by Alen A. Schwartz, MD, edited by Julliana Edwards. About our team →